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Abstract
The macromolecular assembly required to initiate transcription of protein-coding genes, known as the Pre-Initiation
Complex (PIC), consists of multiple protein complexes and is approximately 3.5 MDa in size. At the heart of this assembly is
the Mediator complex, which helps regulate PIC activity and interacts with the RNA polymerase II (pol II) enzyme. The
structure of the human Mediator–pol II interface is not well-characterized, whereas attempts to structurally define the
Mediator–pol II interaction in yeast have relied on incomplete assemblies of Mediator and/or pol II and have yielded
inconsistent interpretations. We have assembled the complete, 1.9 MDa human Mediator–pol II–TFIIF complex from purified
components and have characterized its structural organization using cryo-electron microscopy and single-particle
reconstruction techniques. The orientation of pol II within this assembly was determined by crystal structure docking and
further validated with projection matching experiments, allowing the structural organization of the entire human PIC to be
envisioned. Significantly, pol II orientation within the Mediator–pol II–TFIIF assembly can be reconciled with past studies
that determined the location of other PIC components relative to pol II itself. Pol II surfaces required for interacting with
TFIIB, TFIIE, and promoter DNA (i.e., the pol II cleft) are exposed within the Mediator–pol II–TFIIF structure; RNA exit is
unhindered along the RPB4/7 subunits; upstream and downstream DNA is accessible for binding additional factors; and no
major structural re-organization is necessary to accommodate the large, multi-subunit TFIIH or TFIID complexes. The data
also reveal how pol II binding excludes Mediator–CDK8 subcomplex interactions and provide a structural basis for Mediator-
dependent control of PIC assembly and function. Finally, parallel structural analysis of Mediator–pol II complexes lacking
TFIIF reveal that TFIIF plays a key role in stabilizing pol II orientation within the assembly.
Citation: Bernecky C, Grob P, Ebmeier CC, Nogales E, Taatjes DJ (2011) Molecular Architecture of the Human Mediator–RNA Polymerase II–TFIIF Assembly. PLoS
Biol 9(3): e1000603. doi:10.1371/journal.pbio.1000603
Academic Editor: Gregory A. Petsko, Brandeis University, United States of America
Received July 27, 2010; Accepted February 4, 2011; Published March 29, 2011
Copyright:  2011 Bernecky et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the NCI (P01 CA112181 and R01 CA127364). CB and CCE were supported in part by NIH grant T32 GM065103 or T32
GM07135. The funders had no role in the study design, data collection and analysis, decision to publish, or in the preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Taatjes@colorado.edu
Introduction
In humans, the transcription initiation machinery consists of
Mediator, pol II, TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and
TFIIH and approximates 3.5 MDa in size. This large assembly
can exist in various structural and functional states [1]. When not
in an activated state that supports transcription initiation, this
assembly is best described as a Pre-Initiation Complex (PIC) [2].
At 1.2 MDa, Mediator represents a major component within the
human PIC and based upon biochemical assays, Mediator helps
assemble and stabilize the PIC [3,4]. Human Mediator is known
to functionally interact with most PIC components, including
TFIIB, TFIID, TFIIE, TFIIH, and pol II itself [3,5–9]. Although
Mediator appears critical for controlling the assembly and activity
of the PIC, a structural basis for these observations has not been
established.
Structural analysis of the human transcription initiation
machinery has been hindered by several factors, including the
large size and complexity of the machinery itself. Although it is
well-established from biochemical assays that pol II physically
interacts with human Mediator [5,7], little is known about the pol
II–Mediator interface. Attempts to structurally define the pol II–
Mediator interface have been made in yeast, but these have been
limited to incomplete assemblies of Mediator and/or pol II
[10,11]. Perhaps as a consequence, these studies have provided
inconsistent predictions of pol II orientation relative to Mediator
itself [12,13]. Because structural data are not available for the
complete Mediator–pol II assembly, even the most basic
information about human PIC structure remains unknown, such
as how PIC components might assemble together with Mediator at
a promoter. For instance, it is not known how pol II orients upon
interaction with Mediator. Because the location of other PIC
factors (TFIIA, TFIIB, TBP, TFIIE, TFIIF, TFIIH) has been
determined relative to pol II itself [14–18], identifying the pol II
orientation when bound to Mediator would help define the
structural organization of the entire 3.5 MDa human PIC. Thus,
structural analysis of the Mediator–pol II assembly represents an
essential, yet missing, link to defining the molecular architecture of
the human PIC. It is also unclear how the interaction of Mediator
and pol II permits simultaneous assembly of the large, 1.1 MDa
TFIID complex as well as other PIC components—such as TFIIB,
TFIIE, and TFIIF—that interact directly with pol II during
transcription initiation. Finally, Mediator is required for TFIIH-
dependent pol II CTD phosphorylation within the human PIC
[9], yet it is not established how the pol II CTD might track within
the PIC, nor is it known what structural features within the
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Mediator–pol II assembly could allow for regulation of TFIIH-
dependent pol II CTD phosphorylation.
The large size, low-abundance, and dynamic features of the
human Mediator complex prevent an analysis using high-
resolution techniques such as X-ray crystallography or NMR
spectroscopy. However, structural analysis of Mediator is well-
suited for cryo-EM studies, which require sub-microgram
quantities of purified protein and can potentially resolve alternate
conformational states of macromolecular complexes. We purified
two different sub-assemblies within the 3.5 MDa PIC: the
1.8 MDa Mediator–pol II binary complex and the 1.9 MDa
Mediator–pol II–TFIIF assembly. In each case, Mediator was
bound to the activation domain of VP16. Cryo-EM analysis of
each assembly revealed the overall structural organization of the
entire human PIC and identified a role for TFIIF in stabilizing
Mediator–pol II interactions. Our results establish Mediator as the
scaffold around which the entire human PIC assembles and reveal
a pol II-induced structural shift within Mediator that likely
precludes Mediator binding to the CDK8 submodule. Collective-
ly, these observations provide a structural basis for initiation and
post-initiation regulatory events and further define how Mediator
coordinates PIC assembly and function.
Results
Isolation of Human Mediator–pol II–TFIIF or Mediator–
pol II Complexes
In order to assemble the Mediator–pol II–TFIIF complex or the
Mediator–pol II binary complex, we first purified Mediator, pol II,
and TFIIF independently. Human TFIIF was purified following
recombinant expression in E. coli, whereas pol II and Mediator
were each isolated as endogenous complexes from HeLa cells.
Mediator purification involved an affinity resin using the
activation domain of VP16 (residues 411–490), yielding VP16-
bound Mediator complexes [19]. Each complex (TFIIF, VP16-
Mediator, and pol II) was purified to near-homogeneity, as shown
in Figure 1A–C. We completed mass spectrometry analysis of
Mediator and pol II, primarily to confirm that these purified
complexes contained each of their consensus subunits: 26 subunits
within Mediator and 12 subunits for pol II (Table 1). With the
purified, 26-subunit Mediator complex and the 12-subunit pol II
complex in hand, we next tested whether Mediator and pol II
and/or Mediator, pol II, and TFIIF would associate to form a
stable assembly that could be isolated and imaged using electron
microscopy.
To isolate the Mediator–pol II–TFIIF assembly, pol II and
TFIIF (added in excess to pol II) were incubated together for 1 h
at 4uC. Mediator was then added and all three factors were
incubated together for an additional hour at 4uC. After
incubation, the sample containing Mediator, pol II, and TFIIF
was loaded onto a glycerol gradient (Figure 2A). The gradient was
designed such that the complete, 1.9 MDa Mediator–pol II–
TFIIF assembly would migrate and concentrate within the final 1–
2 fractions, whereas free Mediator or pol II would mostly sediment
within earlier gradient fractions (Figure 2B and unpublished data).
As a 100 kDa dimer, free TFIIF sedimented much earlier in the
gradient (Figure 2B). The presence of Mediator, pol II, and TFIIF
within the final gradient fraction—denoted fraction A—was
confirmed by immunoblotting experiments (Figure 2E). Because
TFIIF alone sediments much earlier than fraction A, this
immunoblotting result provided biochemical evidence that
Mediator, pol II, and TFIIF were forming a stable, ternary
complex.
To investigate the potential impact of TFIIF on the Mediator–
pol II structure, we also isolated a Mediator–pol II binary complex
using a method similar to that described for isolation of Mediator–
pol II–TFIIF (Figure 2C). The glycerol gradient corresponding to
the Mediator–pol II experiment showed a silver-stain pattern
consistent with the presence of both Mediator and pol II in the last
fraction (fraction B, Figure 2D), as expected. Western blot
experiments confirmed the presence of Mediator and pol II in
this fraction, whereas TFIIF—which was not added in this
protocol—was not detected (Figure 2E).
To further confirm that TFIIF was present together with
Mediator and pol II in gradient fraction A (Figure 2B), but absent
in gradient fraction B (Figure 2D), we used an in vitro
transcription assay consisting of purified and recombinant human
factors [20]. Because this assay requires reconstitution of the
transcription machinery from purified components, transcription
initiation will not occur if a PIC component (e.g. TFIIF) is not
added to the reaction. An outline of the transcription assay is
shown in Figure 2F. Following addition of activator (GAL4-p53),
the general transcription factors TFIIA, IIB, IID, IIE, and IIH
were added to chromatin templates, together with fraction A or
fraction B. As shown in Figure 2G, transcription reactions that
were not supplemented with a glycerol gradient fraction (and
therefore lacked Mediator, pol II, and TFIIF) were inactive, as
expected (lane 1). Upon supplementation with gradient fraction A,
transcription was activated in a dose-dependent manner (lanes 2–
4). By contrast, supplementation with gradient fraction B, which
contains Mediator and pol II but lacks TFIIF, was unable to
support transcription (lanes 5–7). Taken together, the data in
Figure 2G further demonstrated TFIIF was present with Mediator
and pol II within glycerol gradient fraction A, whereas TFIIF was
absent from glycerol gradient fraction B.
Initial EM Analysis of the Mediator–pol II–TFIIF Assembly
Given the functional (Figure 2G) and biochemical (Figure 2E)
evidence that Mediator, pol II, and TFIIF formed a stable
assembly, we next examined this sample (fraction A) using EM.
We first imaged negatively stained samples and collected both
untilted (0u) and tilted (25u–45u) images to produce an ab initio
random conical tilt reconstruction [21]. Examination of untilted
micrographs revealed a relatively homogenous field of particles
with a size and shape consistent with an intact, 1.9 MDa
Author Summary
Transcription initiation in humans is regulated by a
macromolecular complex formed by the RNA polymerase
II enzyme (pol II), Mediator, and the general transcription
factors TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH. Collective-
ly, these factors are known as the Pre-Initiation Complex
(PIC). Although the 1.2 MDa Mediator seems to have a
major role in regulating assembly and function of the PIC,
a structural understanding of the complex has yet to be
established. This study outlines a cryo-EM analysis of the
Mediator–pol II assembly in the presence or absence of the
dimeric TFIIF complex. We observe that TFIIF is required to
stably orient the pol II enzyme within the Mediator–pol II
assembly, indicating a novel structural role for TFIIF in
transcription initiation. Additionally, we accurately dock
the pol II crystal structure within the human Mediator–pol
II–TFIIF cryo-EM map. The locations of TFIIH, TBP (a subunit
within TFIID), TFIIA, TFIIB, TFIIE, and TFIIF relative to the pol
II enzyme itself have been determined by previous studies.
These data in combination with the Mediator–pol II–TFIIF
structure described here allow us to propose the structural
organization of the entire 3.5 MDa human PIC.
Architecture of Mediator-pol II-TFIIF
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Mediator–pol II–TFIIF assembly (Figure S1A). Reference-free 2D
classification followed by back-projection and cross-correlation of
the corresponding 3D model structures established a homogenous
data set that represented 36% of all single-particle images. This
data set was then used to generate an initial reference volume,
which was subjected to iterative projection matching [22] to
produce a final, refined structure at 42 A˚ resolution (Figure S1B–
D). A number of reprojections of the refined, Mediator–pol II–
TFIIF structure are compared with those of Mediator alone in
Figure S1E to highlight the significant change in protein density
within the Mediator head region. Based upon this comparison, it
was evident that pol II interacts with the Mediator head domain,
as observed previously with yeast Mediator–pol II complexes
[10,23]. This Mediator–pol II–TFIIF structure, obtained from
negatively stained samples using the random conical tilt method-
ology, served as a starting point for cryo-EM refinement of
Mediator–pol II–TFIIF assemblies.
Cryo-EM Reconstruction of Mediator–pol II–TFIIF
Our studies using negatively stained samples indicated that
VP16-Mediator, pol II, and TFIIF could form a stable assembly
that was amenable to 3D reconstruction using single-particle
methods. We next obtained EM data from the same sample (i.e.
fraction A, Figure 2B) using cryo-EM techniques, which allows for
samples to be imaged in a fully hydrated state, offering the
potential for higher resolution structural information and imple-
Figure 1. Purification of factors used in this study. (A) Schematic outlining the purification of human TFIIF and a Coomassie stained gel of the
resulting purified material. (B) Schematic outlining the purification of endogenous human pol II and a silver stained gel of the purified complex.
* Probable breakdown product of RPB1. This band is recognized by RPB1 antibodies in immunoblot experiments and its presence increases in
proportion to the number of times the purified pol II sample is freeze-thawed. Pol II utilized for EM analysis was not freeze-thawed, whereas the silver-
stained pol II sample shown here was freeze-thawed once. (C) Purification overview for human VP16-Mediator and a silver stained gel of the purified
material. Also shown is a glycerol gradient purification of this sample (right). Mediator-containing fractions (13–15) that were subjected to MS analysis
(Table 1) are highlighted.
doi:10.1371/journal.pbio.1000603.g001
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mentation of a powerful 3D variance technique [24] to assess
potential structural variability within the sample.
Cryo-EM micrographs of Mediator–pol II–TFIIF were col-
lected and screened for astigmatism and sample stage drift (see
Materials and Methods). The best 106 micrographs were selected,
from which 10,856 single-particle images were obtained for image
processing. A representative micrograph and its corresponding
power spectrum is shown in Figure S2A and S2B. The initial
Mediator–pol II–TFIIF structure, generated from negatively
stained samples, was low-pass filtered to 57 A˚ resolution and used
as an initial reference volume for iterative projection matching
refinement. Initial refinement with the cryo-EM data improved
the structure, but the resolution leveled off at around 48 A˚. This
suggested some conformational or compositional heterogeneity
within the cryo-EM data set. Such heterogeneity was in fact
expected, as VP16-Mediator was added in excess of pol II during
the isolation of the Mediator–pol II–TFIIF assembly and a
fraction of complexes within the cryo-EM data set should
correspond to free VP16-Mediator.
To partition the cryo-EM data into distinct complexes we
carried out multi-reference refinement using as references the
negative stain reconstructions of the free VP16-Mediator structure
[19] and the Mediator–pol II–TFIIF assembly structure, each
filtered to 57 A˚ (see Materials and Methods). Using this protocol,
individual cryo-EM images were aligned to re-projections of each
distinct reference (VP16-Mediator or Mediator–pol II–TFIIF) and
partitioned to the structure that yielded the highest cross-
correlation. In this way, the cryo-EM data set was separated into
two, more homogenous groups. The free VP16-Mediator cryo-
EM structure that resulted from this refinement is shown in Figure
S3, whereas different views of the Mediator–pol II–TFIIF
assembly are shown along the left panel of Figure 3A (see also
Movie S1). Importantly, separation of free VP16-Mediator images
from Mediator–pol II–TFIIF significantly improved the resolution
of the Mediator–pol II–TFIIF reconstruction from 48 A˚ to 36 A˚
(Figure S2C), based upon the FSC criterion (or 26 A˚ using the 3s
criterion). The distribution of particle orientations within the
Mediator–pol II–TFIIF data set was fairly isotropic, although
proportionally fewer end-on views were observed (Figure S2D).
To further assess the quality of the Mediator–pol II–TFIIF cryo-
EM 3D reconstruction, we generated reference-free 2D class
averages from the cryo-EM data set, using a k-means clustering
algorithm [25]. As expected, 2D classes resembling Mediator–pol
II–TFIIF or the free VP16-Mediator structure were observed.
These 2D class averages—generated without any reference bias—
were then compared with 2D class averages derived from re-
projections of the Mediator–pol II–TFIIF assembly shown in
Figure 3A. As shown in Figure S4A, the reference-free 2D class
averages closely matched reference-based 2D class averages
derived from re-projections of the refined Mediator–pol II–TFIIF
structure, supporting the validity of the cryo-EM reconstruction.
Similarly, the reference-free 2D class averages closely matched 2D
class averages derived from re-projections of the free VP16-
Table 1. Mass spectrometry data for human pol II (A) and
human Mediator (B) samples.
A
Approx. MW (KDa) Pol II Subunit Percent Coverage
220 RPB1 29.2
130 RPB2 32.7
35 RPB3 25.5
17 RPB4 40.8
26 RPB5 29.5
18 RPB6 8.7
22 RPB7 35.5
17 RPB8 46.7
15 RPB9 67.2
12 RPB10 14.2
10 RPB11 14.2
8 RPB12 16.4
B
Approx. MW (KDa) Mediator Subunit Percent Coverage
220 MED1 14.4
36 MED4 17.0
33 MED6 24.8
34 MED7 15.0
32 MED8 19.9
16 MED9 11.6
16 MED10 9.6
13 MED11 23.9
150 MED14 11.3
105 MED15 13.6
95 MED16 8.3
78 MED17 10.3
28 MED18 11.1
26 MED19 4.5
23 MED20 16.0
19 MED21 12.5
16 MED22 21.4
130 MED23 4.3
100 MED24 7.9
92 MED25 5.8
70 MED26 18.3
37 MED27 3.5
20 MED28 11.8*
24 MED29 26.7
25 MED30 14.0
18 MED31 26.7
A mass spectrometry (MS) protocol was used to define the composition of
Mediator and pol II that was used for EM analysis. These data confirm the
purification protocols outlined in Figure 1B and Figure 1C isolated the
complete, 26-subunit Mediator complex and the entire, 12-subunit pol II
enzyme. Peptide identification and percent coverage was calculated following a
1% false-discovery rate (FDR) analysis.
*No unique peptides corresponding to MED28 remained following the 1% FDR
screen; however, two unique MED28 peptides were present in the MS data and
these were manually validated and are shown in Figure S11. The 11.8% value
listed for MED28 reflects the inclusion of these two peptides. Thus, it does not
Table 1. Cont.
appear that MED28 dissociates from Mediator during the purification protocol
outlined in Figure 1C. Note also that whereas CDK8 and Cyclin C were not
detected in this sample, MED12 (2.6% coverage) and MED13 (0.8% coverage)
were detectable; based upon the silver stained gel of VP16-Mediator (Figure 1C)
as well as comparison of spectral counts and percent coverage, it is evident
these subunits are substantially sub-stoichiometric relative to core Mediator
subunits in this VP16-Mediator sample.
doi:10.1371/journal.pbio.1000603.t001
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Figure 2. Purification and activity of Mediator–pol II–TFIIF or the Mediator–pol II binary complex. (A) Schematic outlining the isolation
of the Mediator–pol II–TFIIF assembly from individually purified components. Note Mediator was purified bound to the VP16 activation domain
(residues 411–490). (B) Silver stained polyacrylamide gel of glycerol gradient fractions from the purification outlined in (A). Subunits are labeled at
Architecture of Mediator-pol II-TFIIF
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Mediator structure (Figure S4B). We also completed protocols to
ensure that refinement of Mediator–pol II–TFIIF was not
negatively impacted by model bias [26]; these experiments are
described in Materials and Methods. Additional strategies were
implemented to further refine the Mediator–pol II–TFIIF cryo-
EM structure; however, improvement of the resolution beyond
36 A˚ was not achieved, likely because of flexibility inherent within
the 1.9 MDa assembly (see below). Importantly, the 36 A˚
resolution assembly structure is sufficient for accurate pol II
docking studies (Figure S5).
RNA Polymerase II Orientation Within the Mediator–pol
II–TFIIF Assembly
We utilized two complementary approaches to determine the
orientation of pol II within the Mediator–pol II–TFIIF assembly.
We began by docking a crystal structure of yeast pol II into the
cryo-EM density map using the program Situs [27]. Docking pol
II with Situs represents a rigorous, unbiased way in which to
probe pol II orientation, and regardless of where the pol II
crystal structure was initially positioned (e.g. outside the cryo-EM
map or within the leg domain or within the head domain), Situs
calculated the same docking result. Rigid body docking of the
pol II atomic model indicated a best fit within the Mediator head
region (Figure 3A, center panels; see also Movie S1), as expected
based on comparison of the structure with that of Mediator
alone. Note the pol II atomic model shown throughout this
article is PDB 1Y1V [28]. This model was chosen because it
most closely matches the human pol II structure determined by
cryo-EM [29]. However, docking calculations completed with
over a dozen distinct pol II crystal structures yielded the same
results (Table S1). The orientation of the pol II cleft in this
docking model is perpendicular to the long axis of Mediator such
that downstream DNA would extend from the ‘‘top’’ of the
assembly. This pol II orientation can readily accommodate
binding of other PIC factors (see Discussion). As an alternate
means of determining the orientation of pol II within the
Mediator–pol II–TFIIF assembly, we used a projection matching
strategy (see Materials and Methods) in which 2D projections of
the human pol II cryo-EM structure [29] were aligned and cross-
correlated with 2D projections of the human Mediator-pol II-
TFIIF assembly. This independent analysis resulted in the same
pol II orientation within the Mediator–pol II–TFIIF assembly as
that calculated by docking of the yeast pol II crystal structure
(Figure S6).
Given the consistent pol II docking calculations, corroborated
by the projection matching data, it was evident that pol II adopted
a stable orientation within the Mediator–pol II–TFIIF assembly.
The pol II orientation calculated from these alternate methods
indicated the pol II cleft was exposed at one end of the assembly
(Figure 3A). Because 2D projections of a 3D volume allow an
assessment of protein density throughout the volume, 2D
projection views from the ‘‘top’’ and ‘‘bottom’’ of the Mediator–
pol II–TFIIF structure should provide an additional means to
probe the location and orientation of the pol II cleft. As shown in
Figure 3B and Figure 3C, the 2D projection views reveal an area
deficient in protein density that overlaps precisely with the pol II
cleft, offering an additional verification of the pol II docking and
projection matching results.
The cryo-EM structure of the entire Mediator–pol II–TFIIF
assembly shown in Figure 3A was reconstructed using 46% of the
data. Single-particle images were included in the reconstruction
based upon a cross-correlation threshold. Two additional 3D
reconstructions were completed de novo in which a greater
percentage of the cryo-EM data was included, based upon
adjusting the cross-correlation threshold (see Materials and
Methods). As before, the multi-reference refinement protocol
was implemented. Single-particle images were free to align to
reference projections derived from either of the major entities
present in the sample: the free VP16-Mediator structure or the
Mediator–pol II–TFIIF complex. In each case (62% or 55% of the
data was included in the analysis, instead of 46%), the Mediator–
pol II–TFIIF assembly refined to essentially the same structure as
shown in Figure 3A, including an identical docking solution for pol
II. However, the resolution did not improve, and small areas of
structural discontinuity became evident with the larger data sets,
likely due to inclusion of alternate conformational states. These
results suggested that inherent flexibility within the Mediator–pol
II–TFIIF assembly was limiting the ultimate resolution of the
reconstruction. In support of this, we further probed for alternate
Mediator–pol II–TFIIF structural states using 3D variance
analysis [24], which yielded no structure distinct from that shown
in Figure 3A (see Materials and Methods).
A comparison of the free VP16-Mediator structure (Figure S3
and [19]) with that of the Mediator–pol II–TFIIF assembly
indicates that Mediator itself undergoes significant structural shifts
upon binding pol II–TFIIF. Structural shifts occur not only at the
Mediator–pol II interface, but also throughout the complex,
including the Mediator leg domain (Figure S7). As a consequence,
difference map calculations (e.g. VP16-Mediator with or without
bound pol II–TFIIF) are not informative. Despite the limited
sequence conservation between yeast and human Mediator (Table
S2), it is notable that global structural shifts are also observed upon
pol II binding to yeast Mediator [10]. A scheme outlining human
VP16-Mediator structural shifts that occur upon pol II–TFIIF
binding is shown in Figure S7.
Initial EM Analysis of the Mediator–pol II Binary Complex
Upon completion of the cryo-EM reconstruction of Mediator–
pol II–TFIIF, we next analyzed the Mediator–pol II sample
(Figure 2D, fraction B) using EM. As with the Mediator–pol II–
TFIIF assembly, EM analysis of fraction B began with analysis of
negatively stained samples to generate an initial Mediator–pol II
structure. As expected, extra density in this structure was apparent
within the head domain of Mediator, indicating that pol II
associates with the Mediator head domain even in the absence of
TFIIF. A description of the EM image processing of the Mediator–
pol II data with random conical tilt, negatively stained samples is
provided in Materials and Methods.
right. Fraction A denotes the fraction containing the 1.9 MDa Mediator–pol II–TFIIF assembly. (C) Purification scheme used for isolation of the
Mediator–pol II binary complex. (D) Silver stained gel of the odd fractions of the glycerol gradient resulting from the purification outlined in (C).
Mediator and pol II subunits are listed at the right. Fraction B denotes the sample containing Mediator–pol II. (E) Western blot analysis of pol II (anti-
RPB1), Mediator (anti-MED23), and TFIIF (anti-Rap74), which confirms the presence of TFIIF in fraction A and the absence of TFIIF in fraction B. (F)
Schematic of the transcription assay used to investigate the activity of the isolated Mediator–pol II assemblies. Note that Mediator, pol II, and TFIIF are
excluded from these assays. (G) The isolated Mediator–pol II–TFIIF assembly is transcriptionally active. In vitro transcription indicates the isolated
Mediator–pol II–TFIIF assembly (fraction A) can reconstitute activated transcription from reactions lacking these factors, whereas a Mediator–pol II
assembly lacking TFIIF cannot (fraction B).
doi:10.1371/journal.pbio.1000603.g002
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Figure 3. RNA polymerase II adopts a stable orientation within the Mediator–pol II–TFIIF assembly. (A) Left: different views (rotation
shown at left) of the cryo-EM 3D reconstruction of the Mediator–pol II–TFIIF assembly, rendered to 1.8 MDa; center: the pol II crystal structure (red;
PDB 1Y1V) is shown docked within the Mediator–pol II–TFIIF cryo-EM map (blue mesh); right: the pol II crystal structure displayed on its own, with
characteristic pol II orientations denoted in red font. Note the docked pol II crystal structure shows only the polypeptide backbone and does not
correspond to the overall electron density map, whereas the cryo-EM map represents electron density (i.e. a space-filling rendering). A space-filling
model of the pol II ‘‘front’’ view is shown (inset) for reference. (B) The top view of the Mediator–pol II–TFIIF assembly cryo-EM structure rendered in
the ‘‘solid’’ view using Chimera [59]. Bright areas indicate higher protein density. This rendering allows clear visualization of the pol II cleft. (C) A
reprojection view (panel 1) of the Mediator–pol II–TFIIF 3D reconstruction that further highlights the location of the pol II cleft in the structure; panel
2 shows Mediator–pol II–TFIIF in the same orientation, rendered in the ‘‘solid’’ view using Chimera.
doi:10.1371/journal.pbio.1000603.g003
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Cryo-EM Reconstruction of Mediator–pol II Reveals Key
Structural Role for TFIIF
The 3D reconstruction of the Mediator–pol II binary complex
obtained from negatively stained samples was used as a starting
model for cryo-EM analysis of the complex 141 cryo-micrographs,
screened for astigmatism and sample drift, were used (Figure S8A).
As with the Mediator–pol II–TFIIF cryo-EM reconstruction, image
processing was initiated using a multi-reference approach. The low-
pass filtered (to 57 A˚) free VP16-Mediator structure [19] and the
Mediator–pol II structure (generated from negatively stained
samples) were used as initial references. Throughout the refinement
it was evident the Mediator–pol II data set was more structurally
heterogeneous than the Mediator–pol II–TFIIF sample (see
Materials and Methods). As a result, initial refinements of
Mediator–pol II contained regions of discontinuity, suggesting the
presence of multiple conformational states within the Mediator–pol
II data set. By contrast, data that partitioned to the free VP16-
Mediator structure—the second volume included in this initial
multi-reference protocol—refined normally: its resolution improved
throughout the refinement and its structure matched the previously
published structure of VP16-Mediator [19].
To probe for additional conformational states within the
Mediator–pol II cryo-EM data, we implemented a 3D variance
and focused classification procedure [24]. This identified a region of
peak structural variance near the pol II binding site (region 1, Figure
S9). Cryo-EM images within the Mediator–pol II data set were then
sorted into two groups based on focused classification within this
region (see Materials and Methods). Two new Mediator–pol II
reference structures that resulted from this classification were then
used for angular refinement against the cryo-EM data set. Thus, a
new multi-reference angular refinement was completed that
partitioned the data into one of three reference volumes: free
VP16-Mediator, or two distinct Mediator–pol II substructures.
Structure refinement improved substantially with this revised multi-
reference procedure. In particular, each of the two Mediator–pol II
substructures refined to an improved resolution (34 A˚ for
substructure 1; 36 A˚ for substructure 2), and structure discontinuity
was eliminated. The 3D reconstruction of each Mediator–pol II
structure is shown in Figure 4; see also Figure S8B–E.
To define the orientation of pol II within each Mediator–pol II
structural state, docking experiments were completed using Situs
[27]. In contrast to the Mediator–pol II–TFIIF structure, however,
a high-confidence docking result could not be attained for either
Mediator–pol II complex (substructure 1 or substructure 2).
Although pol II localized consistently to the Mediator head domain
region in each substructure, its orientation was variable and
undefined (Figure 4). Projection matching experiments provided
similar results in that a defined, stable pol II orientation was not
evident for Mediator–pol II substructure 1 or substructure 2
(unpublished data). Because the same Mediator sample and the
same pol II sample were used to assemble both Mediator–pol II–
TFIIF and Mediator–pol II (see Materials and Methods), it appears
the absence of TFIIF is solely responsible for the dramatically
different structure of the Mediator–pol II complex relative to
Mediator–pol II–TFIIF. From these data, we conclude that pol II
can associate with Mediator in the absence of TFIIF, but pol II does
not adopt a stable orientation. By contrast, pol II does adopt a stable
orientation within the Mediator–pol II–TFIIF assembly, suggesting
TFIIF helps orient and stabilize pol II when bound to Mediator.
Discussion
Although the proteins and protein complexes required to
regulate transcription initiation have been known for some time,
an understanding of how the initiation machinery assembles and
functions as a unit has remained elusive. One reason for this is that
PIC structure has not been examined in the context of the major
architectural factor within the PIC—the human Mediator
complex. The cryo-EM study outlined here involved a stable
assembly of three different multi-subunit complexes: the 26-
subunit Mediator complex, the 12-subunit pol II complex, and the
dimeric TFIIF complex. We observed that the Mediator–pol II–
TFIIF ternary complex was more stable than the Mediator–pol II
binary complex. Whereas cross-linking was not required to
assemble the ternary complex, TFIIF was clearly important for
Figure 4. Pol II does not stably orient within Mediator in the absence of TFIIF. The two distinct Mediator–pol II substructures are shown.
The location of pol II within each structure—based upon docking the pol II crystal structure (PDB 1Y1V) in Situs [27]—is denoted by the orange
sphere. The orientation of pol II, however, could not be reliably determined from docking or projection matching calculations; it appears that multiple
pol II orientations exist in the absence of TFIIF.
doi:10.1371/journal.pbio.1000603.g004
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stabilizing the orientation of pol II within the assembly. This
observation defines a structural role for TFIIF within the PIC that
likely contributes to its requirement for transcription initiation. We
propose that TFIIF makes simultaneous contacts with both
Mediator and pol II to stabilize the assembly; however, further
experiments will be required to confirm this.
The human Mediator complex is large and structurally
dynamic. Not only does pol II binding induce structural shifts in
Mediator, but activator binding or CDK8 submodule binding also
triggers substantial structural shifts throughout the complex [30].
Structural plasticity is also inferred from bioinformatics studies
that predict an unusually high percentage of intrinsically
disordered regions within Mediator subunits [31]. This structural
flexibility appears to be essential for the biological activity of the
human Mediator complex [9,32]. We employed numerous image
processing strategies that partitioned the Mediator–pol II–TFIIF
cryo-EM data into groups with improved structural homogeneity.
Although successful, the ultimate resolution of the assembly did
not exceed 36 A˚ (0.5 FSC criterion, or 26 A˚ using the 3s
resolution assessment). A cryo-EM study of the 21-subunit yeast
Mediator complex resulted in a 28 A˚ structure (0.5 FSC criterion),
and a cryo-EM study of the 12-subunit human pol II enzyme
yielded a 22 A˚ resolution structure [12,29]. As with the yeast
Mediator cryo-EM study, structural flexibility within the pol II
enzyme was cited as a limiting factor to obtaining higher
resolution. As a 1.9 MDa assembly of three distinct protein
complexes containing 40 subunits, human Mediator–pol II–TFIIF
represents the largest transcription assembly ever examined using
cryo-EM. Because of the dynamic nature of the complexes within
this assembly, we anticipate that chemical fixation or crystalliza-
tion will be required to obtain structural information that is
substantially higher resolution.
Given the importance of defining the correct orientation of pol
II within the Mediator–pol II–TFIIF assembly, we implemented a
series of different techniques to confirm the docking result. First,
identical docking results were obtained from independent EM data
sets, including the random conical tilt negative stain data and the
cryo-EM data. Second, three different, de novo cryo-EM recon-
structions yielded essentially identical structures with the same pol
II docking result. Third, identical pol II docking results were
calculated from over 20 different pol II crystal structures (e.g. PDB
1Y1V, 1NT9, etc.). Fourth, pol II projection matching experi-
ments, which represent a completely distinct means of evaluating
pol II orientation, yielded a result consistent with the pol II
docking experiments. Fifth, features resembling the pol II stalk and
cleft are clearly visualized within the refined cryo-EM map and the
locations of these features coincide precisely with the pol II crystal
structure docking results. Finally, and perhaps most compelling,
the calculated orientation of pol II within the Mediator–pol II–
TFIIF assembly can be reconciled with existing biophysical studies
that localized other GTFs within the PIC relative to pol II itself
(see below).
Structural Model of the Complete, 3.5 MDa Human PIC
Several labs have used X-ray crystallography or crosslinking
experiments to determine where the general transcription factors
TFIIA, TFIIB, TBP, TFIIE, TFIIF, and TFIIH reside in the PIC
relative to pol II itself [14–18,33,34]. Because pol II adopts a
defined orientation within the Mediator–pol II–TFIIF assembly,
the structural data from previous studies can now augment the
Mediator–pol II–TFIIF cryo-EM map. By merging these data, the
structural organization of the entire human PIC can be proposed
(Figure 5A). Importantly, the location and orientation of pol II
within the cryo-EM assembly is completely consistent with
previous structural studies that examined pol II and other general
transcription factors. For example, surfaces along pol II shown to
be required for interaction with TFIIB and TFIIE are exposed and
accessible in the Mediator–pol II–TFIIF assembly [15–17].
Furthermore, no significant structural rearrangements appear
necessary to accommodate the large, multi-subunit TFIID and
TFIIH complexes (Figure S10) [35,36]. The pol II cleft, which
interacts with promoter DNA, is also accessible in the Mediator–
pol II–TFIIF assembly and an unobstructed path for the upstream
and downstream DNA can be envisioned (Figure 5A). Along the
surface of the pol II subunit RPB2, the entry site for NTPs (the
pore and funnel) is accessible as is the docking site for potential
interactions with TFIIS (Figure 5B) [28,37].
The fact that previous structural models of pol II together with
TFIIB, TFIID, TFIIE, or TFIIH can be incorporated within the
human Mediator–pol II–TFIIF cryo-EM map offers further
validation of the cryo-EM structure and the pol II docking results.
By contrast, these same structural models are not compatible with
the various structures proposed for yeast Mediator-yeast pol II
(Figure S10) [10,11,13]. At least four factors might contribute to
the differences observed between the human and yeast PIC
models. First and foremost, the cryo-EM study outlined here
involves the entire, 26-subunit human Mediator complex and the
complete, 12-subunit human pol II enzyme. No structural study in
yeast has examined the entire 12-subunit pol II enzyme together
with Mediator; moreover, pol II docking calculations—which
represent the most rigorous, unbiased means to determine pol II
orientation within an EM map—have not been completed with
yeast factors. One yeast PIC model is based upon a recent EM
study that examined a 7-protein yeast Mediator head module and
two subunits of yeast pol II, RPB4 and RPB7 [11]. Yet
biochemical experiments indicate the 7-subunit yeast head module
does not interact with the pol II CTD, nor can it stably interact
with the entire pol II enzyme [38]; additional Mediator subunits
are required for pol II binding. The pol II–Mediator interface is
extensive and clearly involves more than the 7-subunit Mediator
head module and does not require the RPB4/7 subunits [10,23].
Consequently, an alternate pol II orientation proposed from EM
analysis of the 7-subunit yeast Mediator and RPB4/7 dimer likely
derives from the fact that interactions required for stable pol II–
Mediator binding could not occur [11]. Further supporting this
idea, pol II orientation within the yeast pol II-yeast Mediator
assembly appears to shift substantially when the entire yeast
Mediator complex is examined together with a 10-subunit pol II
enzyme that lacks RPB4/7 [10,23]. Modeling the RPB4/7 stalk
into the EM structure of yeast Mediator bound to the 10-subunit
pol II enzyme orients RPB4/7 toward the middle/tail domain of
yeast Mediator [13], whereas the study with the 7-subunit yeast
head module proposes that RPB4/7 physically interacts with the
Mediator head domain [11]. A second potential reason for the
structural differences proposed for yeast Mediator-pol II complex-
es is that structural studies in yeast have not examined Mediator
and pol II together with TFIIF; the structural data outlined here
indicate TFIIF plays a major role in orienting human pol II
relative to Mediator itself. Third, our structural studies examined
human Mediator bound to the activation domain of VP16,
whereas structural studies with yeast Mediator and yeast pol II did
not examine Mediator bound to any activation domain. Lastly,
whereas pol II and several other general transcription factors (e.g.
TFIIB, TFIIE, TFIIF) are relatively well-conserved, Mediator is
poorly conserved between yeast and humans (Table S2). Thus, it is
plausible that the human transcription initiation machinery may
adopt a distinct architecture relative to that coordinated by yeast
Architecture of Mediator-pol II-TFIIF
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Mediator. A summary comparing structural studies with yeast and
human Mediator–pol II complexes is shown in Table 2.
Transcription Initiation and Elongation
The human pol II enzyme contains a C-terminal domain (CTD)
within its RPB1 subunit that is approximately 500 residues in
length and is largely unstructured. The pol II CTD interacts with
the human Mediator complex; in fact, the pol II CTD can be used
to affinity purify Mediator from partially purified extracts [5].
Immediately adjacent to the RPB4/7 stalk region is the point from
which the pol II CTD extends from the pol II enzyme (asterisk,
Figure 5B). Because the pol II CTD is unstructured, it cannot be
reliably localized within the Mediator–pol II–TFIIF cryo-EM
map, nor has it been resolved from pol II crystal structure data.
Based upon existing biochemical and biophysical studies, however,
we propose the region highlighted green in Figure 5B represents
the probable location of the pol II CTD within the PIC. This
region corresponds to the site of pol II CTD–Mediator interaction
identified previously using EM coupled with antibody labeling
experiments with human Mediator bound to the pol II CTD [5].
Furthermore, this proposed pol II CTD location (Figure 5B) is
proximal to the putative Cyclin H/CDK7 kinase module site
within the human PIC (Figure 5A). Phosphorylation of the pol II
CTD correlates with transcription initiation and elongation, and
CDK7—a TFIIH subunit—is the major pol II CTD kinase within
the PIC. The XPB/ERCC3 subunit within human TFIIH has
been shown to interact with DNA elements just downstream of the
transcription start site [14], which places TFIIH in an orientation
Figure 5. Structural model of the entire, 3.5 MDa human PIC. (A) The ‘‘front’’ and ‘‘side 1’’ views of the Mediator–pol II–TFIIF cryo-EM map
(blue mesh) are shown. The docked pol II enzyme is shown in red. The locations of TBP, TFIID, TFIIA, TFIIB, TFIIF, TFIIE, and TFIIH are superimposed
upon the cryo-EM map and are based upon existing crystallography, EM, and cross-linking studies [14–18,36]. The likely path of upstream and
downstream promoter DNA is also shown (dashed line). (B) The binding site for TFIIS is shown, along with the NTP entry and RNA exit sites within the
assembly [28,37]. The putative location of the pol II CTD is shown in green (see text). The Mediator densities labeled ‘‘1’’ and ‘‘2’’ correspond to the
head domain. The asterisk denotes the site from which the pol II CTD extends from the enzyme. (C) Ribbon diagram of pol II alone, shown in the same
orientation as in (B). Individual pol II subunits colored as shown.
doi:10.1371/journal.pbio.1000603.g005
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such that its CDK7/Cyclin H lobe would be positioned near the
proposed location of the pol II CTD in the Mediator–pol II–
TFIIF structure. Although additional structural studies will be
required to confirm the precise orientation of TFIIH within the
human PIC, such TFIIH–pol II CTD co-localization also supports
biochemical data that indicate a Mediator requirement for TFIIH-
dependent pol II CTD phosphorylation within promoter-bound,
human transcription complexes [9].
During transcription initiation, the newly transcribed RNA exits
the pol II enzyme along the pol II RPB4/7 stalk [39,40]. Within
the Mediator–pol II–TFIIF assembly, the RPB4/7 stalk is oriented
such that the nascent RNA could extend unobstructed from the
PIC (Figure 5B). Thus, the architecture of the assembly ensures the
transcript is readily accessible for capping enzymes and other
RNA processing factors. Similarly, the pol II CTD emerges from
the pol II enzyme at an exposed site adjacent to the RPB4/7 stalk
(Figure 5B). In addition to binding Mediator within the PIC, the
pol II CTD serves as an assembly platform for many RNA
processing factors (e.g. capping, splicing, cleavage, and poly-
adenylation factors) and is critical for generating stable, mature
transcripts [41]. Based upon the Mediator–pol II–TFIIF assembly
structure, RNA processing factors would have unhindered access
to the pol II CTD.
Upon the transition from initiation to elongation, pol II must
break contacts with the PIC. From a structural standpoint, it is
currently unclear how pol II makes this transition; however, such a
transition likely involves additional structural alterations within
Mediator. Based upon the Mediator–pol II–TFIIF assembly
structure, a portion of the Mediator head domain (1, Figure 5B)
could pivot with a simple hinge-like motion back toward domain 2
(Figure 5B) to facilitate pol II promoter escape. In this way,
Mediator could help regulate the pol II transition from initiation to
elongation. Interestingly, activator-induced structural shifts within
Mediator have been linked to activation of promoter-bound pol II
complexes to a productively elongating state, indicating that
activators likely contribute to this regulation [9]. Incorporation of
additional PIC factors (e.g. TFIIE, TFIIH) might also trigger
structural shifts in Mediator to facilitate pol II promoter escape. A
conformational shift also occurs within pol II itself upon its
transition to an elongating state and also when single-stranded
DNA enters the active-site cleft [42]. These structural shifts may
also disrupt pol II–Mediator contacts to favor promoter clearance
and elongation. Further structural and functional studies will be
required to better define how pol II–Mediator contacts are
affected during the early stages of initiation.
Perhaps most striking about the Mediator–pol II–TFIIF
structure is that the majority of Mediator would remain exposed
even upon assembly of the entire PIC (Figure 5A). Most of the
surface area within the ‘‘body’’ of Mediator and all within the
‘‘leg’’ domain would remain accessible for potential protein-
protein interactions. One well-established interaction involving the
Mediator leg domain is with the 600 kDa CDK8 subcomplex, and
biochemical and functional assays reveal the CDK8 subcomplex
and pol II interact with Mediator in a mutually exclusive fashion
[20,32]. For example, the CDK8 subcomplex will not bind
Mediator–pol II. The interface between the CDK8 subcomplex
and the leg domain of Mediator is extensive and requires the
Med13 subunit within the CDK8 subcomplex [20]. In fact, the
CDK8 subcomplex contains a hook-like structural domain
(Figure 6A) that interfaces with a complementary-shaped surface
within the leg domain of VP16-Mediator (Figure 6B). This
structural complementarity is abolished upon interaction with pol
II, despite the fact that pol II binds the Mediator head domain
over 100 A˚ from the leg domain–Med13 interface (Figure 6C).
The pol II-induced structural shift within the leg domain is also
observed without TFIIF—that is, even when pol II is not stably
oriented within Mediator (Figure 6D and 6E). This structural shift
in the leg domain likely occludes the Med13 interaction site,
thereby regulating Mediator–CDK8 subcomplex interactions.
The mutually exclusive CDK8 subcomplex/pol II interactions
with Mediator suggest a dynamic exchange at actively transcribing
genes. Detachment of pol II from Mediator likely accompanies
promoter clearance and transcription elongation and would allow
subsequent CDK8 subcomplex–Mediator association [20]. This
association would act to prevent a second pol II enzyme from
immediately re-engaging the promoter. CDK8 subcomplex–
Mediator association following pol II promoter clearance might
also enable CDK8-Mediator to regulate transcription elongation.
The human CDK8 subcomplex was recently identified as a
regulator of transcription elongation for genes within the serum
response network [43], and CDK8-Mediator appears to interact
with elongation factors, including P-TEFb [32]. Potentially, pol II
Table 2. Comparison of EM studies with Mediator and RNA polymerase II.
Organism Yeast Yeast Human Human
Composition Mediator (21 subunits) Mediator (7 subunits)c Mediator (26 subunits) Mediator (26 subunits)
Pol II (10 subunits)b RPB4 and RPB7 Pol II (12 subunits) Pol II (12 subunits)
TFIIF (2 subunits)
EM method negative stain negative stain cryo-negative stain cryo-negative stain
Initial data set ,3,000 particles ,8,000 particles 10,856 particlese 7,962 particlese
Final data seta 393 particles 1,332 particles 4,994–6,731 particlesd 1,687 particles and 1,990
particlesf
Resolution ,35 A˚ 30–35 A˚ 36 A˚ 34 A˚ and 36 A˚
Reference 10 11 This study This study
aThe number of single-particle images included in the final angular refinement: the structurally homogenous data set.
bPol II in this sample was missing RPB4 and RPB7.
cYeast Mediator head module.
dDifferent subsets of the data could be used that yielded similar structures with identical pol II docking results.
eParticle number includes free VP16-Mediator, which was also present in these samples and was refined independently (e.g. see Figure S3).
fTwo distinct Mediator–pol II substructures were observed in the absence of TFIIF.
doi:10.1371/journal.pbio.1000603.t002
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might remain in proximity to Mediator during elongation [44],
which would allow a means by which CDK8-Mediator could
simultaneously prevent re-initiation of transcription while affecting
ongoing elongation events. Although further studies are required
to explore this possibility, it is notable that ChIP data indicate
Mediator occupancy within coding regions of active genes [45,46],
suggesting a juxtaposition of Mediator and pol II elongation
complexes.
Materials and Methods
Isolation of Mediator–pol II–TFIIF or Mediator–pol II
Complexes
VP16-Mediator and pol II were individually purified as
endogenous complexes from HeLa nuclear extracts, whereas the
two subunits of TFIIF, Rap74 and Rap30, were expressed
recombinantly in E. coli and purified as described [20]. For each
purification protocol (Mediator–pol II–TFIIF, Figure 2A, or
Mediator–pol II, Figure 2C), the same Mediator and pol II
samples were used. That is, a single, purified VP16-Mediator
sample and a single, purified pol II sample were each split in half,
with half of each sample used for the Mediator–pol II–TFIIF
experiment and half for the Mediator–pol II experiment. The C-
terminal domain (CTD) within the largest subunit of pol II, RPB1,
can be extensively phosphorylated and this phosphorylation can
negatively impact pol II association with Mediator [47]. Although
the majority of the purified pol II sample appeared to be hypo-
phosphorylated, we incubated pol II over a phosphatase resin
(Sigma P0762) for 4 h at 4uC to ensure complete de-phosphor-
ylation of the pol II CTD. This thoroughly de-phosphorylated pol
II sample was used for the purifications outlined in Figure 2A and
Figure 2C. The parallel Mediator–pol II and Mediator–pol II–
TFIIF preparations were applied to separate glycerol step
gradients. The gradient was designed to concentrate the full
assemblies in the bottom fraction, while dispersing smaller
complexes in earlier fractions. The gradient contained the
following amounts of glycerol (in 20 mM HEPES, 100 mM
EDTA, 150 mM KCl, 0.02% NP-40) from bottom to top:
100 mL 35%, 300 mL 30%, 800 mL 25%, and 800 mL 15%. The
gradients were centrifuged at 55,000 rpm for 6 h at 4uC. The
bottom (35%) glycerol gradient fraction was used for EM studies.
Antibodies
Mediator was detected in Western blotting experiments using
an antibody to Mediator subunit MED23 (Bethyl Cat. #A300-
425A). Pol II was detected using an antibody to RPB1 (Santa Cruz
sc-899), which detects both the hyper- and hypo-phosphorylated
forms. TFIIF antibody (Rap74) was purchased from Austral
Biologicals (Cat. #TM-101D-55).
Mass Spectrometry
The purified VP16-Mediator complex (,1 mg) and pol II
complex (,2 mg) fractions were precipitated at 4uC using 20% (v/
v) TCA, 0.067 mg/mL insulin, and 0.067% (w/v) deoxycholate.
Precipitated protein pellets were washed twice with 220uC
acetone and air dried. Proteins were trypsin digested using a
modified Filter-Aided Sample Prep (FASP) protocol [48]. Briefly,
protein pellets were suspended with 4% (v/v) SDS, 0.1 M Tris
pH 8.5, 10 mM TCEP, and incubated 30 min ambient to reduce
disulfides. Reduced proteins were diluted with 8 M Urea, 0.1 M
Tris pH 8.5. and iodoacetamide was added to 10 mM and
incubated 30 min in total darkness. Reduced and alkylated
proteins were then transferred to a Microcon YM-30 spin
concentrator and washed twice with 8 M Urea, 0.1 M Tris
pH 8.5 to remove SDS. Three washes with 2 M Urea, 0.1 M Tris
pH 8.5 were performed, then trypsin and 2 mM CaCl2 was added
and incubated approximately 2 h in a 37uC water bath. Digested
peptides were eluted and acidified with 5% (v/v) formic acid.
Peptides were desalted online and fractionated with a
Phenomenex Jupiter C18 (5 mm 300 A˚; 0.256150 mm) column
using a two-dimensional LC/MS/MS method (Agilent 1100).
Seven steps of increasing acetonitrile (3, 6, 9, 12, 16, 20, and 100%
Figure 6. Pol II-induced structural rearrangements block potential Mediator-CDK8 subcomplex interactions. (A) Two views of the
human CDK8 subcomplex [20]. (B) Structure of the human Mediator complex, bound to the activation domain of VP16 [19]. The CDK8 module hook
domain binds the leg region (boxed area) of Mediator. Note the structural complementarity between the CDK8 submodule hook domain and the
Mediator leg domain. Rearrangements in the leg region that ablate structural complementarity with the CDK8 submodule hook domain occur upon
pol II binding in the presence (C) or absence (D,E) of TFIIF.
doi:10.1371/journal.pbio.1000603.g006
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B; A: 20 mM ammonium formate pH 10, 4% acetonitrile; and B:
10 mM ammonium formate pH 10, 65% acetonitrile) at 5 mL/
minute eluted peptides for a second dimension analysis on a
Dionex Acclaim PepMap C18 (3 mm 100 A˚; 0.0756150 mm)
running a gradient at 0.2 mL/minute from 5% to 25% B in
100 min for steps one through six and 10% to 30% B in 100 min
for step seven (A: 4% acetonitrile and B: 80% acetonitrile, both
with 0.1% formic acid pH,2.5). PepMap eluted peptides were
detected with an Agilent MSD Trap XCT (3D ion trap) mass
spectrometer.
All spectra were searched with Mascot v2.2 (Matrix Sciences)
against the International Protein Index (IPI) database version 3.65
with two missed cleavages and mass tolerances of m/z 62.0 Da
for parent masses and 60.8 Da for MS/MS fragment masses.
Peptides were accepted above a Mascot ion score corresponding to
a 1% false discovery rate (1% FDR) determined by a separate
search of a reversed IPI v3.65 database. Peptides were then filtered
and protein identifications were assembled using in-house software
as described [49]. A listing of all polypeptides identified by MS is
shown in Table S3 and Table S4.
In Vitro Transcription
Reconstituted transcription reactions were completed on a
DNA template with tandem GAL4 binding sites assembled into
chromatin, as described [20].
Negative Stain Electron Microscopy
Sample (either Mediator–pol II–TFIIF or Mediator–pol II) was
applied to a glow-discharged carbon-coated copper EM grid (EMS
cat. #CF400-Cu) and washed twice with 5% trehalose buffer
(20 mM HEPES, pH 7.9, 0.1 mM EDTA, and 100 mM KCl).
Grids were floated on a droplet of water and then stained with 2%
uranyl acetate in water. Images were recorded on Kodak SO-163
film using a Tecnai F20 microscope operated at 200 kV. Untilted
(0u) and tilted (25u–45u) specimen images were collected at
29,0006magnification with a defocus range of 21.0 to 23.5 mm.
The film was digitized with a sample-scale pixel size of 4.29
angstroms. Individual particle images were windowed into
1616161 pixel boxes using the Web interface of the SPIDER
image processing software [50]. The untilted images were
subjected to unsupervised (reference-free) 2D classification based
upon a k-means clustering algorithm [25].
For the Mediator-pol II-TFIIF data set, a total of 8,923 tilted
and untilted pairs were selected. Each 2D class—derived from the
untilted data set—contained dozens to hundreds of individual
single-particle images. Particles grouped within the same class
represented complexes with a similar orientation on the EM grid;
particles in different 2D classes represented an alternate
orientation of the assembly (e.g. ‘‘side’’ or ‘‘top’’ views) or
potentially might reflect an alternate conformational state. The
corresponding tilted images within each 2D class were back-
projected to generate 3D model structures, which were then cross-
correlated and subjected to hierarchical clustering using the
statistical program package R [51]. One branch of the cluster
dendrogram contained well-correlating volumes with images that
could be combined into a single converging reference volume, and
these data served as the negative stain data set. The tilted and
untilted data were used for iterative 2D projection matching to
refine the structure.
The initial Mediator–pol II–TFIIF reference volume was
generated from 3,215 tilted images. This reference was then
refined with 6,430 total images (tilted + untilted) using projection
matching with angular steps of 15u, 10u, and 5u. The final
refinement step included 5,047 (78%) of these images. All half-
volumes were individually masked to 2 MDa (to generate non-
identical masks) prior to resolution assessment using the 0.5
Fourier shell criterion [52].
The Mediator–pol II reference volume was generated from
3,134 tilted images. This reference was then refined with 6,268
total images (tilted + untilted). The resolution of this structure
improved more slowly, so angular steps of 15u, 10u, 5u, 4u, 3u, and
3u were used. The final refinement step for this volume included
4,864 (78%) of these images and the 0.5 Fourier shell criterion was
applied to determine the resolution [52].
Because an excess of VP16-Mediator was included in the
sample preparation, we anticipated some free VP16-Mediator
would be present within each data set. To deal with this
heterogeneity, efforts were taken to generate negative stain
structures of Mediator–pol II–TFIIF and Mediator–pol II free
from potential contamination with unbound VP16-Mediator.
Images of free VP16-Mediator were removed using a single round
of projection matching (15u angular step) with two input reference
volumes—the negative stain volume described above and a
previously determined structure of free VP16-Mediator [19].
Particle images with a higher correlation to free VP16-Mediator
were removed from the data set, and both the Mediator–pol II–
TFIIF and Mediator–pol II structures were refined again. This
refinement was identical to that described above, except that only
untilted images were used for projection matching. The Mediator–
pol II–TFIIF structure was refined using 15u, 10u, 5u, and 5u steps
with 2,390 (74%) images included in the final volume. The
Mediator–pol II structure was refined using 15u, 10u, 5u, 5u, and
4u steps with 2,223 (71%) images included in the final volume.
Cryo-Electron Microscopy
Cryo-negative stain samples for electron microscopy were
prepared largely as described [53]. Purified complexes were added
to a glow-discharged thin carbon-coated holey carbon copper
mesh grid (EMS cat. #CF424-50). A buffer containing 5%
trehalose, 20 mM HEPES, 100 mM KCl, and 100 mM EDTA
was used to wash the grid 3 times to remove excess glycerol. The
sample grid was then floated on a drop of stain (1.2 M ammonium
molybdate pH 7.5). Excess stain was blotted away and the grid
was plunge frozen in liquid ethane to vitrify the sample.
Imaging was carried out at liquid nitrogen temperatures under
low-dose conditions on a Tecnai F20 FEG microscope (200 kV).
Images were recorded at 29,0006magnification on Kodak SO-
163 film with a defocus range of21.0 to24.5 mm. Negatives were
then digitized to 4.29 angstroms per pixel using a Microtek
Scanmaker i900 for Mediator-RNA pol II-TFIIF and 4.22
angstroms per pixel using a Nikon Super Coolscan 9000 ED for
Mediator–pol II. Micrographs were screened for astigmatism and
drift using ctfit (within the EMAN [54] software package) by
removing those with distorted or poorly defined Thon rings in the
power spectrum. Individual particle images were manually
selected from high-quality micrographs before being windowed
into 1616161 pixel boxes for further processing.
The contrast transfer function parameters were estimated for
each micrograph using the program CTFFIND3 [55]. Using these
parameters, individual images were CTF-corrected for phase on a
per-micrograph basis. The cryo-EM data set for the Mediator–pol
II–TFIIF assembly included 10,856 images. The cryo-EM data set
for the Mediator–pol II assembly included 7,962 images.
The appropriate negative stain structures or cryo-EM structures
(generated by three-dimensional variance and sub-classification of
images—see below), Butterworth filtered to 57 A˚, served as initial
references for multi-reference projection matching refinement
[56,57]. Multi-reference refinements were completed as described
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[57]. The resolution of each reconstruction was calculated using
the 0.5 Fourier shell criterion [52] or the 3s-threshold criterion
[58]. For Mediator–pol II–TFIIF, using the 0.5 Fourier shell
criterion, the resolution was found to be 36 A˚, whereas using the
3s-threshold criterion indicated 26 A˚ resolution. For Mediator–
pol II substructure 1, the 0.5 Fourier shell and 3s criteria specified
a resolution of 34 A˚ and 29 A˚, respectively. For Mediator–pol II
substructure 2, the 0.5 Fourier shell and 3s criteria indicated 36 A˚
and 31 A˚ resolution, respectively. The reconstructions were
displayed after filtering to the values obtained using the 0.5
Fourier shell criterion.
In order to estimate the degree of structural homogeneity in the
cryo-EM Mediator–pol II–TFIIF data set, several multi-reference
refinements were completed using different percentages of the
data. Volumes were created using 46%, 55%, 62%, or 78% of the
10,856 cryo-EM images, based upon their cross-correlation
coefficient. The structure generated using 78% of the data
converged poorly and resulted in a highly discontinuous structure.
The assembly structures generated using 46%, 55%, or 62% of the
data converged to very similar solutions that cross-correlated in the
0.94–0.98 range. Despite containing additional data, the 55% and
62% reconstructions did not result in an improved resolution, and
trace discontinuities in the volumes appeared at the 1.8 MDa
threshold. Consequently, the assembly reconstruction produced
using 46% of the data set was used for crystal structure docking
and projection matching experiments. Similar refinement trials
were used to determine that 59% of the data would be included in
the final 3D reconstruction of the Mediator–pol II binary complex.
Three-Dimensional Variance and Sub-Classification
To further probe for alternate structural states within the
Mediator–pol II–TFIIF assembly and to potentially separate out
structurally distinct conformers, we carried out a 3D variance
analysis, developed by Penczek and co-workers [24]. This
methodology identifies regions of structural variability by com-
paring the variance within the structure pixel-by-pixel, relative to
background. Focused classification within a region of high
variance has the potential to segregate structurally distinct
assemblies, especially in cases in which the variance is well-
localized and there are a few clearly distinguishable conforma-
tional states. Importantly, this technique has proven effective in
identifying structural flexibility within a number of multi-subunit
complexes, including human transcription complexes [22,29,57].
Implementation of this approach to the Mediator–pol II–TFIIF
data (i.e. data that partitioned to the Mediator–pol II–TFIIF
structure during the multi-reference refinement), however, did not
improve the resolution of the structure overall. In fact, this
approach—which will partition the Mediator–pol II–TFIIF data
to generate two substructures—resulted in two virtually identical
structures with consistent pol II docking orientations. This is likely
indicative of flexibility within the assembly and suggests a relatively
stable Mediator–pol II–TFIIF conformational state about which
the structure oscillates. Taken together with the de novo cryo-EM
reconstruction results described above, these results indicate that
although the structure shown in Figure 3A is stable and represents
a major entity within the Mediator–pol II–TFIIF cryo-EM data
set, the flexible nature of the assembly precludes further
improvement of spatial resolution.
The 3D variance within the refined Mediator–pol II–TFIIF or
Mediator–pol II cryo-EM structures was estimated by creating and
comparing 500 re-sampled volumes using a bootstrap technique as
described [24]. Focused classification within the area of the 3D
reconstruction displaying the highest variance was then used to
separate the data into more homogenous groups [22]. Specifically,
the refined structure was projected in 28 directions (angular
interval of 25 degrees) and each image used in the final round of
angular refinement was matched to the highest correlating
projection. This classification step produced 28 groups of images,
each representing a similar orientation of the assembly, or
‘‘projection groups.’’ The highest peak in the 3D variance density
map was then used to generate a mask for classification by
projection in each of the directions corresponding to the 28 groups
of images. For each projection group, k-means classification within
the mask was used to separate the images into two subclasses,
which in turn were sorted by visual inspection into one of two
groups. Group 1 contained subclasses with less apparent density,
and group 2 contained subclasses with more apparent density. The
original structure was then subjected to one round of refinement
using each group of images to generate two new reference
structures. Finally, multi-reference projection matching was used
to refine these substructures.
Assessment of Potential Model Bias
Whereas the generation of reference-free classes that closely
resembled reprojections of either Mediator–pol II–TFIIF or free
VP16-Mediator indicated that both entities were present within
the cryo-EM data set (Figure S4), we wanted to further confirm
that each structure (Figure 3 and Figure S3) did not result from
model bias [26] during angular refinement. To do this, reciprocal
refinements were completed for Mediator–pol II–TFIIF and free
VP16-Mediator. In one case, the free VP16-Mediator reference
was refined using the data that had previously been partitioned
into the Mediator–pol II–TFIIF data set. As expected, pol II
density was built into the structure and the general shape of the
Mediator–pol II–TFIIF assembly began to emerge during angular
refinement. For example, the cleft between lobes 1 and 2 and the
cleft between lobe 3 and the body/leg of Mediator became re-
defined in the structure (Figure S7 and unpublished data). This
suggested that structural features observed for Mediator–pol II–
TFIIF do not result from initial model bias. In the second case, the
data representing free VP16-Mediator was used to refine an initial
Mediator–pol II–TFIIF reference structure. Again, as expected,
density representing pol II disappeared from the Mediator head
region and the pocket domain located between lobes 1, 2, and 3 of
Mediator emerged during the refinement (Figure S7 and
unpublished data). Because key structural features of the
Mediator–pol II–TFIIF and free VP16-Mediator models were
preserved even when a reference volume lacking these features was
used as a starting point for refinement, model bias did not
negatively impact the cryo-EM reconstructions of either the
Mediator–pol II–TFIIF assembly or the free VP16-Mediator
structure.
Pol II Crystal Structure Docking
A yeast crystal structure of pol II (PDB 1Y1V) [28], with the
TFIIS fragment removed, was roughly fit into the desired EM
structure using Chimera [59]. This visual docking was refined
using the FFT-Accelerated 6D Exhaustive Search program of
Situs [27]. Using the search tool Colores [60], an exhaustive
search of translational and rotational space was performed and as
expected we did not see any dependence of the best docking fit
upon the initial position. Because the 12-subunit yeast pol II
structure 1Y1V was shown previously to fit well into the human
pol II EM structure [29], the 1Y1V structure was chosen to be
displayed. Docking was also completed using each of the complete
12-subunit pol II structures found in the RCSB Protein Data Bank
(1NT9, 1PQV, 1WCM, 1Y1W, 1Y1Y, 1Y77, 2B8K, 2B63, 2JA5,
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2JA6, 2JA7, 2JA8, 2VUM, 3FKI, 3HOU, 3HOV, 3HOW,
3HOX, 3HOY, 3HOZ, 3K1F), with identical results.
Pol II Projection Matching
The orientation of pol II was also determined using 2D projection
matching [10] of projection averages of each cryo-EM structure
(Mediator–pol II–TFIIF or Mediator–pol II) and re-projections
generated from a previously published cryo-negative stain human pol
II 3D model [29]. The refined 3D reconstruction (Mediator–pol II–
TFIIF or Mediator–pol II) was projected into 84 directions
(15uintervals) and each image included in the reconstruction was
matched to the best-correlating projection. Images from each
projection group were aligned in 2D and averaged to yield a ‘‘view
average.’’ Because many projections of the Mediator–pol II–TFIIF or
Mediator–pol II assembly structures contain overlapping Mediator
and pol II densities, density contributions from pol II alone often
could not be distinguished. To ensure the most accurate comparison
of pol II features, the view average corresponding to the projection of
the assembly that had the least amount of Mediator density
overlapping with pol II density was used for this analysis. Re-
projections of the human pol II structure were generated using a 5u
angular step for a total of 1,596 projections. Each of these projections
was matched to the area of the assembly 2D projection average
containing pol II (as determined by Situs docking).
A plot was generated to visualize areas of best correlation for a
single projection average. The axes of the plot are the phi and
theta angles. Larger points indicate higher correlation between a
particular 2D re-projection of pol II and the projection average of
the assembly structure. For ease of viewing the peak correlations,
the radius of each point is proportional to 10 raised to the
studentized residual (10 (value - mean)/standard deviation). Each cluster of
large points indicates a well-correlating orientation of pol II. The
highest correlation was observed with an orientation of pol II that
closely matched the 3D docking result (Figure S6).
Supporting Information
Figure S1 Negative stain EM analysis of the Mediator–pol II–
TFIIF assembly. (A) Negative stain micrograph of the Mediator–
pol II–TFIIF assembly. Scale bar: 100 nm. (B) Several views of the
random conical tilt, negative stain EM reconstruction of the
Mediator–pol II–TFIIF assembly. The structure was refined to
42 A˚ resolution and is shown rendered to 1.8 MDa. (C) Angular
distribution of images included in the Mediator–pol II–TFIIF
negative stain reconstruction. (D) Resolution curve for the negative
stain reconstruction of the Mediator–pol II–TFIIF assembly. The
Fourier shell correlation is shown in blue and the 3s noise curve is
shown in red. (E) Comparison of projections of the Mediator–pol
II–TFIIF assembly and projections of VP16-Mediator only. Extra
density resulting from pol II binding is observed in the head region
of Mediator.
Found at: doi:10.1371/journal.pbio.1000603.s001 (2.39 MB EPS)
Figure S2 Additional information and statistics pertaining to the
Mediator–pol II–TFIIF cryo-EM reconstruction. (A) Cryo-nega-
tive stain micrograph of the Mediator–pol II–TFIIF assembly.
Scale bar: 100 nm. (B) Power spectrum of the micrograph shown
in part A. Micrographs included in the reconstruction display clear
Thon rings indicating a minimum of drift and astigmatism. (C)
Resolution curve for the cryo-EM reconstruction of the Mediator–
pol II–TFIIF assembly. The Fourier shell correlation is shown in
blue and the 3s noise curve is shown in red. (D) Angular
distribution of images included in the Mediator–pol II–TFIIF
cryo-EM reconstruction.
Found at: doi:10.1371/journal.pbio.1000603.s002 (6.16 MB EPS)
Figure S3 The refined VP16-Mediator structure obtained from
the Mediator–pol II–TFIIF cryo-EM data set resembles the
previously published VP16-Mediator structure obtained from
negatively stained samples. (A) Three views of the previously
published negative stain VP16-Mediator reconstruction [19]. (B)
Three corresponding views of the cryo-EM VP16-Mediator
reconstruction. Free VP16-Mediator complexes were present
within the Mediator–pol II–TFIIF data set; these particles were
used to generate an independent 3D reconstruction of VP16-
Mediator from cryo-EM data. (C) Resolution curve for the cryo-
EM reconstruction of VP16-Mediator. The Fourier shell correla-
tion is shown in blue and the 3s noise curve is shown in red. (D)
Angular distribution of images included in the VP16-Mediator
cryo-EM reconstruction.
Found at: doi:10.1371/journal.pbio.1000603.s003 (1.82 MB EPS)
Figure S4 Reference-free 2D classes generated from the cryo-
EM Mediator–pol II–TFIIF data set resemble projections and
views generated from the Mediator–pol II–TFIIF assembly
reconstruction. (A) Representative 2D classes or projections that
correspond to the Mediator–pol II–TFIIF assembly. (B) Repre-
sentative 2D classes or projections that correspond to the free
VP16-Mediator structure, which was also present within the cryo-
EM data set. The similarity of the reference-free classes to the
projections and classes generated using the Mediator–pol II–
TFIIF reconstruction (in A) or the VP16-Mediator reconstruction
(in B) demonstrates that potential bias from the negative stain
reference volumes was minimal. Thresholded proj. refers to 2D
projections generated from the refined, Mediator–pol II–TFIIF
3D reconstruction, masked to a 2.0 MDa threshold; proj.
represents 2D projections generated from the refined, Mediator–
pol II–TFIIF 3D reconstruction that were not thresholded. View
avg refers to 2D class averages generated from actual cryo-EM
data in which 2D projections of the refined assembly guide
classification (i.e. supervised classification); ref-free class avg.
represent 2D classes that resulted from k-means classification (no
reference used) of the entire cryo-EM data set.
Found at: doi:10.1371/journal.pbio.1000603.s004 (2.13 MB EPS)
Figure S5 Structural features of human pol II at 36 A˚
resolution. Shown are the yeast pol II crystal structure alongside
the human pol II complex rendered at 36 A˚ resolution. Note that
at this resolution, major pol II structural features such as the cleft,
jaws, and stalk are clearly defined.
Found at: doi:10.1371/journal.pbio.1000603.s005 (1.65 MB EPS)
Figure S6 Pol II projection matching experiments corroborate
the pol II docking result for the Mediator–pol II–TFIIF assembly.
(A) Plot of the correlations of projections of pol II and a view
average of Mediator–pol II–TFIIF. The phi and theta angles of
the pol II projections are plotted on the y- and x-axes,
respectively. The radius of each point is proportional to the
correlation coefficient for that particular pol II orientation (see
Materials and Methods). The circled cluster of points indicates
the best-correlating orientations of pol II, and the point denoted
by the arrow represents the highest correlating pol II projection.
(B) The projection of Mediator–pol II–TFIIF and view average
used for projection matching (panel 1 and 2); panel 3 shows the
view average with the area containing pol II highlighted (bright
circle). The region within this circle was used for pol II projection
matching. Panel 4 shows the best-correlating pol II projection,
which corresponds to the arrow in (A). (C) A comparison of the
pol II docking result and the orientation determined from
projection matching. Panel 1 shows the docking fit from Situs
[27] with pol II displayed in red ribbon and Mediator–pol II–
TFIIF in blue mesh. Panel 2 shows the projection matching best
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fit, with pol II in light blue and Mediator–pol II–TFIIF in blue
mesh. Panel 3 shows the pol II fit alone, and panel 4 shows the
same pol II orientation shown with the ‘‘solid’’ viewing option
within Chimera [59]. This viewing option allows interior features
to be more apparent and approximates an actual 2D projection
view. (D) The fits from part C shown from an alternate angle—
the ‘‘front’’ view of the Mediator–pol II–TFIIF assembly. Panel 1
shows both the pol II docking fit in red and the pol II projection
matching fit in light blue. The Mediator–pol II–TFIIF density is
shown in blue mesh. Panel 2 shows both pol II fits overlaid,
without the Mediator–pol II–TFIIF cryo-EM density. Panel 3
shows the docking fit only, whereas panel 4 shows the projection
matching fit only. Note the similarity of the pol II orientation
resulting from either the docking or the projection matching
(compare panel 3 and panel 4).
Found at: doi:10.1371/journal.pbio.1000603.s006 (1.65 MB EPS)
Figure S7 Model illustrating Mediator–pol II–TFIIF binding
and Mediator structural shifts induced by pol II–TFIIF binding.
Different views of the free VP16-Mediator structure [19] are
shown in purple; pol II is shown in red ribbon (PDB 1Y1V); the
Mediator–pol II–TFIIF structure is shown in blue. The orientation
and direction from which pol II interfaces with Mediator is based
upon the Mediator–pol II–TFIIF cryo-EM structure shown in
Figure 3A. The ‘‘side 1’’ view highlights three Mediator domains
(labeled 1, 2, 3) and their probable locations following pol II–
TFIIF binding. The Mediator head, body, and leg domains are
labeled alongside the ‘‘top’’ view of VP16-Mediator. Note that
structural shifts occur within the head, body, and leg domains of
Mediator upon pol II–TFIIF binding. Dashed lines indicate pol II
approach from behind the plane. *The RPB4/7 stalk is directed
away from the viewer; **the RPB4/7 stalk is pointed toward the
viewer.
Found at: doi:10.1371/journal.pbio.1000603.s007 (2.49 MB EPS)
Figure S8 Image processing information pertaining to the
Mediator–pol II cryo-EM reconstructions. (A) Cryo-negative stain
micrograph of the Mediator–pol II assembly. Scale bar: 100 nm.
(B) Resolution curve for the cryo-EM reconstruction of Mediator–
pol II, substructure 1. The Fourier shell correlation is shown in
blue and the 3s noise curve is shown in red. (C) Angular
distribution of images included in the cryo-EM reconstruction of
Mediator–pol II, substructure 1. (D) Resolution curve for the cryo-
EM reconstruction of Mediator–pol II, substructure 2. The
Fourier shell correlation is shown in blue and the 3s noise curve
is shown in red. (E) Angular distribution of images included in the
cryo-EM reconstruction of Mediator–pol II, substructure 2.
Found at: doi:10.1371/journal.pbio.1000603.s008 (4.39 MB EPS)
Figure S9 3D variance within the Mediator–pol II cryo-EM
data. The peak areas of 3D variance are shown in blue,
superimposed on each of the two Mediator–pol II substructures.
Single-particle images corresponding to either substructure 1 or
substructure 2 were classified using the 3D variance at region 1.
Note that 3D variance region 1 is exposed within substructure 1
but occupied by protein density within substructure 2. The
Mediator–pol II substructure 1 is shown in peach and substructure
2 is shown in gray.
Found at: doi:10.1371/journal.pbio.1000603.s009 (2.16 MB EPS)
Figure S10 The human PIC model and comparison with yeast
PIC models. (A) Human PIC model based upon this study. In
contrast to the yeast PIC models, the human PIC model contains
an open, complementary surface for TFIID incorporation into
the assembly; upstream and downstream DNA is accessible for
potential interactions with TFIID and other transcription factors;
the TFIIH assembly site, downstream from the transcription start
site, is accessible and positions TFIIH adjacent to the head
domain of human Mediator. Current yeast PIC models are based
upon EM data of yeast Mediator and a 10-subunit yeast pol II
enzyme [10], or EM data of a 7-subunit yeast Mediator head
module with 2 subunits (RPB4/7) of yeast pol II [11]. Note that
pol II orientation is not consistent in these yeast PIC models (e.g.
compare Figure 3, [13], and Figure 5, [11]): RPB4/7 orient
toward the Mediator tail domain in one model [10,13], whereas
RPB4/7 are proposed to interact with the Mediator head
domain in another model [11]. Neither yeast PIC model appears
to be compatible with TFIID binding—the TFIID interaction
surface (adjacent the RPB 3/10/11/12 subunits) is blocked by
Mediator density in these models. Upstream DNA—important
for TFIID interactions and transcription factor binding—is also
blocked by Mediator density in these models. The location of
TFIIH in each yeast PIC model would allow for interaction with
downstream DNA; however, the location of TFIIH in each yeast
PIC model does not appear consistent with biochemical and
biophysical data that indicate yeast TFIIH interacts directly with
the Mediator head module subunit MED11 [61]. (B) Rough
outline of EM structures of human TFIID [36] and TFIIH [35],
shown at approximately the same relative scale as the human
PIC model in (A).
Found at: doi:10.1371/journal.pbio.1000603.s010 (7.97 MB EPS)
Figure S11 MS/MS spectra supporting the presence of MED28
within the VP16-Mediator sample. Shown are representative MS/
MS spectra that identify MED28; MED28 represented the only
Mediator subunit not identified following 1% FDR analysis
(Table 1). Potentially, MED28 could dissociate from Mediator
during the purification procedure (Figure 1C). This does not
appear to be the case, as MED28 peptides appear to be
represented, although not at 99% confidence.
Found at: doi:10.1371/journal.pbio.1000603.s011 (1.01 MB EPS)
Table S1 List of PDB files used for pol II docking calculations.
Note that indistinguishable docking results were calculated for
each 12-subunit pol II structure PDB file. The PDB 1Y1V
structure is shown throughout the article (with the TFIIS density
removed) because this structure was found to correspond most
closely to the human pol II cryo-EM structure [29].
Found at: doi:10.1371/journal.pbio.1000603.s012 (0.04 MB
DOC)
Table S2 Sequence identity of human and yeast Mediator
subunits.
Found at: doi:10.1371/journal.pbio.1000603.s013 (0.07 MB
DOC)
Table S3 Summary of all proteins identified from mass
spectrometry analysis of VP16-Mediator. Sample isolated as
shown in Figure 1C; glycerol gradient fractions 13–15 were
analyzed. Spectral counts corresponding to keratin were removed
from this list.
Found at: doi:10.1371/journal.pbio.1000603.s014 (0.23 MB
DOC)
Table S4 Summary of all proteins identified from mass
spectrometry analysis of pol II. Sample isolated as shown in
Figure 1B. Note that for structural and functional work completed
here, a glycerol gradient sedimentation step was completed in
order to isolate the Mediator–pol II or Mediator–pol II–TFIIF
assemblies. The pol II sample analyzed using mass spectrometry
was evaluated prior to glycerol gradient sedimentation, and thus
sub-stoichiometric contaminants are present in this analysis.
Nonetheless, it is evident from the spectral counts as well as the
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pol II silver-stained gel (Figure 1B) that pol II is predominant in
this sample even prior to the glycerol gradient purification step.
Spectral counts corresponding to keratin were removed from this
list.
Found at: doi:10.1371/journal.pbio.1000603.s015 (0.46 MB
DOC)
Movie S1 Structure of Mediator–pol II–TFIIF. A 3D surface
representation of the cryo-EM reconstruction of Mediator–pol II–
TFIIF, rendered to 1.8 MDa, is shown in solid blue. The structure
is rotated 360 degrees about the horizontal axis, followed by a
rotation of 360 degrees about the vertical axis. The Mediator–pol
II–TFIIF surface is then displayed as blue mesh with a pol II
crystal structure (PDB 1Y1V) shown in red ribbon in its docked
orientation. The cryo-EM structure and docked pol II are then
rotated about the horizontal and vertical axis as before, with the
rotation paused to highlight views of the complex shown in
Figure 3. Scale bar represents 100 A˚.
Found at: doi:10.1371/journal.pbio.1000603.s016 (10.00 MB
MOV)
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